Security key
92859E108
- Security type / class
- Equity / COM
- Total 13F shares
- 2,174,110
- Total 13F value
- $2,803,935
- Share change
- -310,153
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.29
- Number of holders
- 22
- Value change
- -$781,799
- Number of buys
- 8
- Number of sells
- 12
Open additional details 1 more signal available
Report period
Q2 2022
Institutions
22
Top holders
10
VVOS full security history
Ownership snapshot
Full 13F holder table
Vivos Therapeutics, Inc. SEC filings
Vivos Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VVOS - VIVOS THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Gurdev Dave Singh
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5
13F
Highest disclosed value: $1,862,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $1.86M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
Gurdev Dave Singh
$1.73M
VANGUARD GROUP INC
$1.86M
Russell Investments Group, Ltd.
$1.14M
BARD ASSOCIATES INC
$570K
GEODE CAPITAL MANAGEMENT, LLC
$540K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gurdev Dave Singh |
3/4/5
Chief Medical Officer, Director, 10%+ Owner
|
—
mixed-class rows
|
$1,728,844
3,266,372 shares
mixed-class rows
|
— | 05 Aug 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,862,000
695,051 shares
|
— | 31 Mar 2022 |
| Russell Investments Group, Ltd. |
13F
Company
|
—
denominator unverified
|
$1,137,000
424,801 shares
|
— | 31 Mar 2022 |
| BARD ASSOCIATES INC |
13F
Company
|
—
denominator unverified
|
$570,000
212,704 shares
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$540,000
201,748 shares
|
— | 31 Mar 2022 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$456,000
170,264 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
2,174,110
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
23
Q2 2022 holders
22
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|